Company News
06 Sep 2024
Lumos Diagnostics has today announced that it has successfully completed the institutional component of its recently announced A$10.0 million equity raising - raising a total of approximately A$3.1 million from institutional and sophisticated investors.
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
COMPANY NEWS
2 min read
FebriDx® has surpassed 100 healthcare locations across 18 states in the United States
COMPANY NEWS
1 min read
Lumos has achieved enrolment of 250 patients in its BARDA-funded FebriDx® paediatric clinical study, triggering a US$670,000 milestone payment...